Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting

by Marjan Amiri, Tim Schneider, Matthias Oelke, Sandra Murgas, Martin C. Michel
Published 2021-01-01

Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, cont...

by Rúiter Silva Ferreira, Carlos Arturo Levi D’Ancona, Matthias Oelke, Maurício Rassi Carneiro

Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A...

by Marcus J Drake, Matthias Oelke, Robert Snijder, Monique Klaver, Klaudia Traudtner, Karin van Charldorp, Dominique Bongaerts, Philip Van Kerrebroeck
Published 2017-01-01

Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies

by Andrea Tubaro, José E. Batista, Victor W. Nitti, Sender Herschorn, Christopher R. Chapple, Mary Beth Blauwet, Emad Siddiqui, Moses Huang, Matthias Oelke
Published 2017-06-01

Improvement of quality of life and symptom burden after robot-assisted radical prostatectomy in patients with moderate to severe LUTS

by Sami-Ramzi Leyh-Bannurah, Christian Wagner, Andreas Schuette, Nikolaos Liakos, Theodoros Karagiotis, Mikolaj Mendrek, Pawel Rachubinski, Katarina Urbanova, Matthias Oelke, Jorn H. Witt
Published 2021-08-01

Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making

by Anshu Ankolekar, Ben G. L. Vanneste, Esther Bloemen-van Gurp, Joep G. van Roermund, Evert J. van Limbergen, Kees van de Beek, Tom Marcelissen, Victor Zambon, Matthias Oelke, Andre Dekker, Cheryl Roumen, Philippe Lambin, Adriana Berlanga, Rianne Fijten
Published 2019-07-01